New Horizons in Complement-Mediated Kidney Diseases

CME Activities

• Advances in the Management of Complement-Mediated Kidney Diseases: A Year in Review
  Medscape Education, December 2022
  Complement involvement in antibody- and non-antibody-mediated kidney diseases makes targeting complement activation an attractive therapeutic strategy.
• Diagnosis and Management of C3G: A Collaborative Effort Between Pathologists and Nephrologists
  Medscape Education, September 2022
  Did you know that C3 glomerulopathy is now considered a pathological entity instead of a purely glomerular pathology?
  0.50 CME
• An Update on C3 Glomerulopathy: Understanding a Rare Complement-Mediated Kidney Disease
  Medscape Education, August 2022
  C3 glomerulopathy (C3G) is a rare disease, but did you know that up to 70% of children and 50% of adults reach end-stage kidney disease within 10 years of diagnosis?
  0.50 CME
• Challenging Cases of Glomerulonephritis: How Would You Diagnose and Manage These Patients?
  Medscape Education, July 2022
  Can you recognize, diagnose, and manage rare complement-mediated kidney diseases?
  1.00 CME
• Complement in Rare Kidney Diseases: Different Diseases With a Common Denominator
  Medscape Education, June 2022
  How familiar are you with the role of complement pathways in the pathophysiology and management of complement-mediated kidney diseases?
  0.50 CME
• Immunoglobulin A Nephropathy: A Call to Action for Personalized Risk Assessment and Timely Management
  Medscape Education, April 2022
  Join 3 experts in discussion about how to best identify patients at high-risk of progression and the role of proteinuria in IgA nephropathy management.
  0.50 CME